Adaptimmune Therapeutics plc (ADAP)

1.72 ↑0.25 (17.01%)
As of May 19, 2022, 3:09pm EST.

ADAP Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $1.33 - $6.37
  • Market Capitalization: $254.13M
  • Short Percentage: 0%
  • Target Price: $5.67
  • Shares Outstanding: 161.86M
  • Next Earnings: Feb 24
View More Stats

Catalysts

DateCategoryCatalyst
2022-02-24
Earnings

ADAP released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $2.45 Close: +9.80% Next Day: +9.80% Next Week: -10.61% View More
0 Comments Share
Help your fellow traders

News and Press Releases

Company Info

Stock Details

  • Current Price: $1.72
  • 52-Week Low: $1.33
  • 52-Week High: $6.37
  • Most Recent Quarter: 2022-03-31
  • Shares Float: 88.90M
  • Shares Outstanding: 161.86M
  • Market Capitalization: $254.13M
  • Next Earnings Date: 2022-02-24

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 0.00%

The short interest for Adaptimmune Therapeutics plc is at 0.00%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 23.96%
Insiders: 0.17%
Instutitions: 75.87%

Analyst Target Price

5.67

Adaptimmune Therapeutics plc is currently $4.20 below Wallstreet Analysts' price target.

Yesterday's Volume

121,539

Interest in Adaptimmune Therapeutics plc has been trending down. The average daily volume in the past 14 days is 443,024.

Discussions

Please log in or register to share your thoughts.